U.S., July 23 -- ClinicalTrials.gov registry received information related to the study (NCT07078435) titled 'Innate Immunity, MIcrobiota and Inovative Treatments in Endometriosis' on July 11.
Brief Summary: Endometriosis is a chronic inflammatory, polygenic, and multifactorial disease affecting approximately 10% of women of reproductive age, corresponding to over one million women in France. Endometriosis profoundly impairs the health and quality of life of affected individuals and carries a significant socio-economic burden, making it a major public health concern. To date, the pathogenesis and prognostic factors of disease progression remain poorly understood. Despite current treatment options, which are based on hormonal therapy or surg...